Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study
Vaccines · 24.08.2023 · 11 (9) · 1409
DOI: 10.3390/vaccines11091409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 24.08.2023. Verfasst von Joyce Pijpers und 7 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Surveillance, National Institute for Public Health and the Environment, 3721 MA De Bilt, The Netherlands. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Ministry of Health, Welfare and Sports., Dutch Ministry of Health, Welfare, and Sports.
Abstract (Originalsprache)
By September 2022, the uptake of at least one dose of COVID-19 vaccine in the Dutch adult population was 84%. Ecological studies have indicated a lower uptake in certain population groups. We aimed to investigate determinants of COVID-19 vaccine uptake in the Netherlands at individual level to evaluate and optimize implementation of the vaccination program and generate hypotheses for research on drivers of, and barriers to, vaccination. A retrospective database study was performed including the entire Dutch population ≥ 18. Vaccination data (5 January 2021–18 November 2021) were at individual levels linked to sociodemographic data. Random forest analyses ranked sociodemographic determinants of COVID-19 vaccine uptake. The most important determinant was age; uptake increased until the age of 80 (67% in 18–35 years, 92% in 67–79 years, and 88% in those > 80). Personal income and socioeconomic position ranked second and third, followed by migration status. Uptake was lower among individuals in the lowest income group (69%), those receiving social benefits (56%), and individuals with two parents born abroad (59%). Our finding that age is the most important determinant for uptake likely reflects the prioritisation of elderly in the programme and the general understanding of their increased vulnerability. However, our findings also reveal important other disparities in vaccine uptake. How to best address this inequity in future vaccination campaigns requires further research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Epidemiology and Surveillance, National Institute for Public Health and the Environment, 3721 MA De Bilt, The Netherlands.
- Statistics and Modelling, National Institute for Public Health and the Environment, 3721 MA De Bilt, The Netherlands.
ORCID-Profile: Joyce Pijpers, Lisanne Labuschagne, Hester de Melker
Förderung
- Dutch Ministry of Health, Welfare and Sports.
- Dutch Ministry of Health, Welfare, and Sports
Zitieren
APA
Pijpers, J., van Roon, A., van Roekel, C., Labuschagne, L., Smagge, B., Ferreira, J. A., de Melker, H., & Hahné, S. (2023). Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study. Vaccines, 11(9), 1409. https://doi.org/10.3390/vaccines11091409
Vancouver
Pijpers J, van Roon A, van Roekel C, Labuschagne L, Smagge B, Ferreira JA, et al. Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study. Vaccines. 2023;11(9):1409. doi:10.3390/vaccines11091409
BibTeX
@article{Pijpers2023,
author = {Pijpers, Joyce and van Roon, Annika and van Roekel, Caren and Labuschagne, Lisanne and Smagge, Bente and Ferreira, José A and de Melker, Hester and Hahné, Susan},
title = {Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {9},
pages = {1409},
doi = {10.3390/vaccines11091409}
}
EUVIMED